A clinical trial to study the effect of giving gabapentin before minor surgery affects pain during and after the surgical procedure
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/01/061816
- Lead Sponsor
- Dr Ranganath V S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing minor surgery under local anesthesia who have ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
Patients with known allergies or sensitivity to gabapentin.
Regular gabapentin use within the past 1 month or previous treatment with gabapentin
Substance Abuse and any known allergy to pain-killers including NSAIDs and opioids.
Participants who are pregnant, lactating, or planning to conceive during the study.
Patient with hepatic or renal impairment
Any history of a pre-existing seizure or major psychiatric disorder.
Patients taking antidepressants or anti-convulsant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS (Visual Analogue Scale),NRS (Numeric Rating scale), Requirement of analgesic or opioids perioperatively <br/ ><br>Timepoint: 2, 4-, 6-, 12-hours post-surgery and peri-operative
- Secondary Outcome Measures
Name Time Method Patient-reported side effects of the interventional drug, Gabapentin. (Treatment emergent side effects). <br/ ><br>Time for first analgesic or opioid requirement on patients requestTimepoint: 2, 4-, 6-, 12-hours post-surgery